218 related articles for article (PubMed ID: 30938030)
1. Suppression of long non-coding RNA TNRC6C-AS1 protects against thyroid carcinoma through DNA demethylation of STK4 via the Hippo signalling pathway.
Yang LX; Wu J; Guo ML; Zhang Y; Ma SG
Cell Prolif; 2019 May; 52(3):e12564. PubMed ID: 30938030
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway.
Peng X; Ji C; Tan L; Lin S; Zhu Y; Long M; Luo D; Li H
J Cell Mol Med; 2020 Jan; 24(1):304-316. PubMed ID: 31657132
[TBL] [Abstract][Full Text] [Related]
3. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
Hou S; Lin Q; Guan F; Lin C
J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
Fan L; Li H; Wang W
Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis.
Guo F; Fu Q; Wang Y; Sui G
J Cell Mol Med; 2019 Sep; 23(9):5907-5919. PubMed ID: 31304680
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
7. Silencing long non-coding RNA DLX6-AS1 or restoring microRNA-193b-3p enhances thyroid carcinoma cell autophagy and apoptosis via depressing HOXA1.
Feng L; Wang R; Wang Y; Shen X; Shi Q; Lian M; Ma H; Fang J
J Cell Mol Med; 2021 Oct; 25(19):9319-9330. PubMed ID: 34514705
[TBL] [Abstract][Full Text] [Related]
8. LncRNA STK4 antisense RNA 1 (STK4-AS1) promoted osteosarcoma by inhibiting p53 expression.
Yao W; Hou J; Liu G; Wu F; Yan Q; Guo L; Wang C
Cancer Biomark; 2023; 36(1):1-16. PubMed ID: 35912730
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA LINC00607 silencing exerts antioncogenic effects on thyroid cancer through the CASP9 Promoter methylation.
Li L; Gao Z; Zhao L; Ren P; Shen H
J Cell Mol Med; 2021 Aug; 25(16):7608-7620. PubMed ID: 34232553
[TBL] [Abstract][Full Text] [Related]
10. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
Feng Z; Chen R; Huang N; Luo C
Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
[TBL] [Abstract][Full Text] [Related]
12. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
13. METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.
Lin S; Zhu Y; Ji C; Yu W; Zhang C; Tan L; Long M; Luo D; Peng X
J Clin Endocrinol Metab; 2022 Jan; 107(2):474-490. PubMed ID: 34562008
[TBL] [Abstract][Full Text] [Related]
14. Long Non-coding Antisense RNA TNRC6C-AS1 Is Activated in Papillary Thyroid Cancer and Promotes Cancer Progression by Suppressing TNRC6C Expression.
Muhanhali D; Zhai T; Jiang J; Ai Z; Zhu W; Ling Y
Front Endocrinol (Lausanne); 2018; 9():360. PubMed ID: 30038597
[No Abstract] [Full Text] [Related]
15. Silencing of long noncoding RNA RP11-476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA-138-5p-dependent inhibition of LRRK2.
Zhao Y; Zhao L; Li J; Zhong L
J Cell Physiol; 2019 Nov; 234(11):20980-20991. PubMed ID: 31102261
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA BZRAP1-AS1 silencing suppresses tumor angiogenesis in hepatocellular carcinoma by mediating THBS1 methylation.
Wang W; Chen G; Wang B; Yuan Z; Liu G; Niu B; Chen Y; Zhou S; He J; Xue H
J Transl Med; 2019 Dec; 17(1):421. PubMed ID: 31847842
[TBL] [Abstract][Full Text] [Related]
17. NPSR1-AS1 activates the MAPK pathway to facilitate thyroid cancer cell malignant behaviors via recruiting ELAVL1 to stabilize NPSR1 mRNA.
Ni T; Guo D; Tan L; Xiao Z; Shi Y
Cell Cycle; 2022 Mar; 21(5):439-449. PubMed ID: 35030041
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA_0057209 Acts as ceRNA to Inhibit Thyroid Cancer Progression by Promoting the STK4-Mediated Hippo Pathway
Peng X; Zhu Y; Lin S; Yu W; Zhang C; Tan L; Long M; Luo D; Ji C
Oxid Med Cell Longev; 2022; 2022():9974639. PubMed ID: 35308166
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
